HAE vs TECH · P/E 35, rev $1.36B vs P/E 65, rev $1.22B
Haemonetics Corporation (HAE) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported HAE revenue for 2025-03-29 was $1.36B. Net income was $167.7M. Revenue was up 4.0% from 2024-03-30 to 2025-03-29. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
HAE currently screens at market cap $3.24B and trailing P/E 34.8. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the HAE and TECH stock pages for the full models.
Not investment advice.